4//SEC Filing
Mercier Johanna 4
Accession 0001782135-25-000013
CIK 0000882095other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:51 PM ET
Size
10.5 KB
Accession
0001782135-25-000013
Insider Transaction Report
Form 4
Mercier Johanna
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-11-17$125.83/sh−25,524$3,211,560→ 109,669 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-11-17−25,000→ 73,110 totalExercise: $66.64Exp: 2029-07-24→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2025-11-17$66.64/sh+25,000$1,666,000→ 135,193 total - Sale
Common Stock
2025-11-17$126.26/sh−2,476$312,614→ 107,193 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- [F2]Sales prices for the transactions reported here range from $125.23 to $126.20. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F3]Sales prices for the transactions reported here range from $126.23 to $126.39. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F4]The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001782135
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 6:51 PM ET
- Size
- 10.5 KB